The indirect bilirubin blood test helps show how much unconjugated bilirubin is circulating in the blood before the liver has processed it for removal. Bilirubin comes mainly from the normal breakdown of old red blood cells, then travels to the liver bound to albumin. The liver changes it into direct, or conjugated, bilirubin so it can leave the body in bile. When indirect bilirubin is high, the reason is often increased red blood cell breakdown, reduced liver uptake, or slower liver conjugation. A mild isolated increase can happen with Gilbert syndrome, especially during fasting, illness, dehydration, or physical stress. A higher or changing result may point toward hemolysis, medication effects, inherited bilirubin-processing disorders, or liver disease that needs a broader evaluation. Interpreting the result is easiest when indirect bilirubin is compared with total bilirubin, direct bilirubin, liver enzymes, a complete blood count, reticulocytes, LDH, haptoglobin, and symptoms such as jaundice, dark urine, pale stools, pain, fever, or fatigue.
- Indirect bilirubin is usually calculated by subtracting direct bilirubin from total bilirubin, rather than measured as a fully separate substance.
- A typical adult indirect bilirubin reference range is about 0.2–0.7 mg/dL, but each lab’s range should be used.
- High indirect bilirubin with normal ALT, AST, ALP, CBC, LDH, haptoglobin, and reticulocytes often suggests Gilbert syndrome.
- High indirect bilirubin with anemia, high reticulocytes, high LDH, and low haptoglobin suggests hemolysis.
- Dark urine usually points away from isolated indirect bilirubin, because unconjugated bilirubin is not water-soluble and does not usually enter urine.
- Urgent care is important for jaundice with confusion, severe weakness, chest pain, shortness of breath, fever, severe abdominal pain, black stools, fainting, or rapidly worsening yellowing.
Table of Contents
- What Indirect Bilirubin Measures
- Normal Range and Result Patterns
- High Indirect Bilirubin Causes
- Hemolysis and Red Blood Cell Breakdown
- Gilbert Syndrome and Benign Patterns
- Jaundice, Urine, and Stool Clues
- Follow-Up Tests and Next Steps
- When to Seek Medical Care
What Indirect Bilirubin Measures
Indirect bilirubin is the unconjugated form of bilirubin. It is made when the body breaks down heme, the iron-containing part of hemoglobin in red blood cells and other heme-containing proteins. Most bilirubin production comes from old red blood cells that are removed by the spleen, liver, and bone marrow.
At first, bilirubin is not water-soluble. Because of that, it travels through the bloodstream attached to albumin, a blood protein. The liver then takes it up and uses an enzyme called UGT1A1 to attach glucuronic acid to bilirubin. This process is called conjugation. Once bilirubin is conjugated, it becomes direct bilirubin, which is more water-soluble and can be sent into bile.
Many lab reports include total bilirubin and direct bilirubin. Indirect bilirubin is commonly calculated:
Indirect bilirubin = total bilirubin − direct bilirubin
For example, if total bilirubin is 2.0 mg/dL and direct bilirubin is 0.3 mg/dL, indirect bilirubin is about 1.7 mg/dL. That pattern means most of the bilirubin is indirect.
This distinction matters because different patterns point in different directions. A mostly indirect bilirubin increase often suggests one of three processes:
- The body is making more bilirubin than usual, often from increased red blood cell breakdown.
- The liver is taking up bilirubin less efficiently.
- The liver is conjugating bilirubin more slowly than usual.
A mostly direct bilirubin increase more often suggests liver cell injury, bile duct blockage, cholestasis, or impaired bile flow. When bilirubin is being interpreted with other liver markers, it often helps to compare it with a hepatic function panel, because that panel usually includes bilirubin, albumin, and liver enzymes.
Indirect bilirubin is not the same as “bad bilirubin.” A small amount is always present because red blood cells are constantly being renewed. The concern is the pattern, degree, and clinical context. A mild, stable, isolated indirect bilirubin elevation in a healthy person has a very different meaning from a new indirect bilirubin elevation with anemia, fatigue, dark urine, fever, or abnormal liver enzymes.
Normal Range and Result Patterns
Adult reference ranges vary by laboratory, method, age, and sometimes specimen handling. A common indirect bilirubin range is about 0.2–0.7 mg/dL. Some labs use slightly different upper limits, such as 0.8 or 1.0 mg/dL. Total bilirubin is often roughly 0.2–1.2 mg/dL, while direct bilirubin is often less than about 0.3 mg/dL.
The most useful interpretation is not the number alone, but the fraction. If most of the total bilirubin is indirect, clinicians think about unconjugated hyperbilirubinemia. If a large share is direct, they think more about hepatobiliary disease, bile flow problems, or liver cell injury.
Common bilirubin patterns
| Pattern | Common meaning | Examples |
|---|---|---|
| Mild high indirect bilirubin, normal liver enzymes, normal blood counts | Often a benign conjugation pattern | Gilbert syndrome, fasting, dehydration, recent illness |
| High indirect bilirubin with anemia | Possible increased red blood cell breakdown or ineffective blood cell production | Hemolytic anemia, B12 or folate deficiency, inherited red cell disorders |
| High indirect bilirubin with high reticulocytes, high LDH, low haptoglobin | Strong hemolysis pattern | Autoimmune hemolysis, G6PD deficiency, transfusion reaction, sickle cell disease |
| High total bilirubin with high direct bilirubin | More likely liver, bile duct, or cholestatic pattern | Hepatitis, bile duct obstruction, gallstones, cholestasis, drug-induced liver injury |
| High bilirubin with high ALT or AST | Liver cell injury should be considered | Viral hepatitis, fatty liver inflammation, alcohol-related liver injury, medication injury |
| High bilirubin with high ALP and GGT | Bile flow or bile duct source becomes more likely | Gallstone obstruction, cholangitis, primary biliary cholangitis, primary sclerosing cholangitis |
A mild indirect bilirubin increase is often in the 1–3 mg/dL total bilirubin range, especially with Gilbert syndrome. Hemolysis can also cause modest indirect bilirubin elevations, but the blood count and hemolysis markers usually provide the clue. In many hemolysis cases, the liver can still conjugate much of the extra bilirubin, so indirect bilirubin may rise but not always to extreme levels unless hemolysis is severe or liver processing is also impaired.
Jaundice, the yellowing of the skin or whites of the eyes, often becomes noticeable when total bilirubin rises above roughly 2–3 mg/dL, though this varies by lighting, skin tone, and the examiner’s experience. A person may have a high bilirubin result before visible jaundice appears.
A low indirect bilirubin result is usually not clinically important. Unlike high bilirubin, low bilirubin is rarely used to diagnose disease in routine care.
High Indirect Bilirubin Causes
High indirect bilirubin means unconjugated bilirubin is above the lab’s reference range. The result usually falls into one of several categories: increased bilirubin production, slower liver uptake, reduced conjugation, or a mixed illness pattern.
Increased bilirubin production
The body makes more bilirubin when more heme is being broken down. The most important cause is hemolysis, which means red blood cells are destroyed faster than normal. Other causes include a large resolving bruise or hematoma, recent internal bleeding, transfusion-related red cell destruction, and ineffective erythropoiesis, where developing red blood cells break down in the bone marrow before entering circulation.
Ineffective erythropoiesis can happen with vitamin B12 deficiency, folate deficiency, some bone marrow disorders, and certain inherited anemias. In these cases, bilirubin rises because red cell precursors are being broken down before they mature.
This is where the bilirubin result should be compared with a complete blood count. A normal hemoglobin and normal red blood cell indices make major hemolysis less likely, while anemia, a high reticulocyte count, and abnormal red cell shape can shift the interpretation.
Reduced liver uptake
Some medicines and illness states can reduce how well bilirubin enters liver cells. Rifampin, certain contrast agents, and some other drugs can affect bilirubin transport. Reduced liver blood flow, severe illness, portosystemic shunting, and advanced heart failure can also affect bilirubin handling.
These situations usually require context. A single bilirubin result cannot prove a transport issue. The timing of new medicines, recent imaging contrast, acute illness, or worsening heart symptoms can matter.
Reduced conjugation
The liver may take up bilirubin but conjugate it more slowly. Gilbert syndrome is the most common example. It happens because UGT1A1 enzyme activity is lower than average, so unconjugated bilirubin can rise during triggers such as fasting, dehydration, illness, stress, strenuous exercise, or menstruation.
Rare inherited disorders, such as Crigler-Najjar syndrome, also reduce bilirubin conjugation, but these are usually recognized much earlier in life and can cause much higher bilirubin levels than Gilbert syndrome.
Some medicines can affect UGT1A1 activity or bilirubin metabolism. Atazanavir and indinavir, used in HIV treatment, are well-known examples that can raise unconjugated bilirubin without necessarily meaning liver injury. Irinotecan, a chemotherapy drug, is important because UGT1A1 variation can increase the risk of drug toxicity.
Mixed liver and bilirubin patterns
Not every case fits neatly. Liver inflammation, alcohol-related liver injury, metabolic dysfunction-associated steatotic liver disease, bile duct obstruction, infection, and medication-related liver injury can produce mixed bilirubin patterns. In those cases, direct bilirubin, ALT, AST, ALP, GGT, albumin, and INR become more important than the indirect bilirubin value alone.
A broader liver pattern can be compared with bilirubin and liver enzyme interpretation, especially when jaundice appears with abnormal ALT, AST, ALP, or GGT.
Hemolysis and Red Blood Cell Breakdown
Hemolysis is one of the most important causes of high indirect bilirubin because bilirubin comes mainly from red blood cell turnover. Red blood cells normally live for about 120 days. When they break down too quickly, the body has to process more heme, which creates more bilirubin.
Hemolysis can occur inside blood vessels, called intravascular hemolysis, or mainly in the spleen and liver, called extravascular hemolysis. Both can raise indirect bilirubin. The pattern depends on the cause and severity.
Common causes of hemolysis include:
- Autoimmune hemolytic anemia
- G6PD deficiency, especially after certain infections, foods, or medicines
- Hereditary spherocytosis
- Sickle cell disease
- Thalassemia and other hemoglobin disorders
- Mechanical destruction from some heart valves or devices
- Transfusion reactions
- Severe infections
- Certain medications or toxins
- Microangiopathic hemolytic anemia, such as thrombotic thrombocytopenic purpura or hemolytic uremic syndrome
A typical hemolysis workup includes hemoglobin, hematocrit, reticulocyte count, LDH, haptoglobin, bilirubin fractions, and a peripheral blood smear. A direct antiglobulin test, also called a direct Coombs test, may be ordered if autoimmune hemolysis is suspected.
Hemolysis lab pattern
| Test | Typical hemolysis finding | Why it changes |
|---|---|---|
| Indirect bilirubin | High | More heme is converted into bilirubin |
| Hemoglobin | Low if hemolysis causes anemia | Red cells are being destroyed faster than replaced |
| Reticulocyte count | Often high | Bone marrow releases more young red cells to compensate |
| LDH | Often high | LDH is released from damaged cells, including red blood cells |
| Haptoglobin | Often low | Haptoglobin binds free hemoglobin released during hemolysis |
| Peripheral smear | May show abnormal red cell shapes | Cell shape can point toward the hemolysis cause |
A high indirect bilirubin result by itself does not prove hemolysis. Gilbert syndrome can raise indirect bilirubin without anemia. A recent fast can raise bilirubin in someone with Gilbert syndrome. A large bruise can temporarily increase bilirubin production. That is why the CBC, reticulocyte count, LDH, haptoglobin, and smear are so helpful.
The peripheral smear can add important clues. Spherocytes may suggest hereditary spherocytosis or autoimmune hemolysis. Schistocytes can suggest mechanical or microangiopathic red cell damage. Bite cells can appear in oxidative hemolysis, including G6PD deficiency. These findings need clinical interpretation, but they can quickly narrow the possibilities.
When hemolysis is suspected, it is also useful to compare indirect bilirubin with haptoglobin results and a reticulocyte count. A low haptoglobin and high reticulocyte count support increased red cell destruction or loss, while normal values make active hemolysis less likely.
Gilbert Syndrome and Benign Patterns
Gilbert syndrome is a common inherited bilirubin-processing pattern. People with Gilbert syndrome have reduced UGT1A1 enzyme activity, so the liver conjugates bilirubin more slowly. The result is usually mild, intermittent unconjugated hyperbilirubinemia.
A typical Gilbert syndrome pattern looks like this:
- Mildly high total bilirubin, often fluctuating
- Mostly indirect bilirubin
- Normal ALT, AST, ALP, and GGT
- Normal hemoglobin and CBC
- Normal reticulocyte count
- Normal LDH and haptoglobin
- No evidence of active liver disease or hemolysis
Total bilirubin in Gilbert syndrome is often below about 4 mg/dL, though it may vary. Many people are diagnosed after routine blood work shows a mild bilirubin elevation. Some notice mild yellowing of the eyes during illness, dehydration, fasting, very low-calorie dieting, intense exercise, stress, or menstruation. Others have no symptoms at all.
Gilbert syndrome does not usually require treatment and does not usually damage the liver. The main value of recognizing it is avoiding unnecessary worry and repeated testing once other concerning causes have been reasonably excluded.
A common real-life pattern is a person who feels well, has total bilirubin around 1.5–2.5 mg/dL, direct bilirubin around 0.2–0.4 mg/dL, and normal ALT, AST, ALP, CBC, LDH, haptoglobin, and reticulocytes. If this pattern has appeared more than once, especially during fasting or illness, Gilbert syndrome becomes likely.
Still, Gilbert syndrome should not be used to explain every bilirubin result automatically. New symptoms, rising bilirubin, abnormal liver enzymes, anemia, dark urine, pale stools, abdominal pain, fever, or weight loss should prompt a broader evaluation. A person can have Gilbert syndrome and still develop another condition later.
Genetic testing for UGT1A1 is not always needed. It may be considered when the diagnosis is unclear, when bilirubin is higher than expected, when there are medication decisions involving UGT1A1 metabolism, or when a specialist wants confirmation. For most mild, classic cases, the pattern of labs and absence of hemolysis or liver disease is enough for clinical diagnosis.
Gilbert syndrome also matters for some medicines. For example, irinotecan toxicity risk can be higher in people with certain UGT1A1 variants. Atazanavir and indinavir can raise unconjugated bilirubin by affecting UGT1A1. A person with known Gilbert syndrome should tell their clinician before starting medicines that affect bilirubin metabolism.
Jaundice, Urine, and Stool Clues
Jaundice means yellowing of the skin, whites of the eyes, or mucous membranes from bilirubin buildup. It is often easier to see in the sclera, the white part of the eyes, than in the skin. The presence of jaundice does not tell you whether bilirubin is direct or indirect. The fractionated bilirubin test does that.
Urine and stool clues can help. Indirect bilirubin is not water-soluble and is tightly bound to albumin, so it is not usually filtered into urine. For that reason, isolated indirect hyperbilirubinemia usually does not cause bilirubin-positive dark urine.
Dark tea-colored urine is more concerning for direct bilirubin in the urine, which suggests conjugated hyperbilirubinemia from liver cell injury or impaired bile flow. Pale, gray, or clay-colored stools can occur when too little bile pigment reaches the intestine, which can happen with bile duct obstruction or severe cholestasis.
Itchy skin, especially with high direct bilirubin, ALP, and GGT, can point toward cholestasis. Right upper abdominal pain, fever, and jaundice together are concerning because they can occur with bile duct infection or obstruction. Severe fatigue, nausea, easy bruising, confusion, swelling, or black stools can suggest more serious liver or blood problems.
How symptoms change interpretation
| Symptom or sign | Possible meaning | Usual next thought |
|---|---|---|
| Mild yellow eyes during fasting or illness | Can fit Gilbert syndrome | Check fractionated bilirubin and confirm other labs are normal |
| Dark urine | Suggests direct bilirubin in urine | Look for liver, bile duct, or cholestatic pattern |
| Pale or clay-colored stool | Reduced bile pigment reaching the gut | Evaluate bile duct obstruction or cholestasis |
| Fatigue with anemia | Possible hemolysis or impaired blood cell production | Check CBC, reticulocytes, LDH, haptoglobin, smear, iron/B12/folate as appropriate |
| Jaundice with fever and abdominal pain | Possible infection, hepatitis, gallstone obstruction, or cholangitis | Needs prompt medical assessment |
| Confusion with jaundice | Possible severe liver dysfunction or serious systemic illness | Emergency evaluation is appropriate |
Indirect bilirubin can also rise in newborns, but newborn jaundice is a separate clinical situation with different thresholds and risks. Babies are treated more cautiously because very high unconjugated bilirubin can affect the brain. Adult reference ranges and adult decision points should not be applied to infants.
Follow-Up Tests and Next Steps
The best follow-up depends on the bilirubin pattern and the person’s symptoms. A mild, isolated indirect bilirubin elevation in a well adult may only need repeat testing and basic hemolysis markers. A higher bilirubin level, anemia, abnormal liver enzymes, or symptoms may need a broader workup.
Common follow-up tests include:
- Repeat total and direct bilirubin, preferably when well hydrated and not fasting
- ALT, AST, ALP, GGT, albumin, and total protein
- CBC with red blood cell indices
- Reticulocyte count
- LDH
- Haptoglobin
- Peripheral blood smear
- Direct antiglobulin test if autoimmune hemolysis is possible
- Urinalysis for bilirubin and urobilinogen
- Iron studies, vitamin B12, and folate when anemia patterns suggest them
- Hepatitis testing or autoimmune liver tests when liver enzymes are abnormal
- Ultrasound if bile duct obstruction, gallstones, or cholestasis is suspected
The sequence often starts with a simple question: Is the bilirubin mostly indirect, mostly direct, or mixed?
If it is mostly indirect, the next question is whether there is hemolysis. The peripheral blood smear, reticulocyte count, LDH, and haptoglobin help answer that.
If hemolysis markers are normal and liver enzymes are normal, Gilbert syndrome becomes a common explanation. If liver enzymes are abnormal, clinicians usually evaluate liver inflammation, bile flow problems, alcohol-related injury, metabolic risk, viral hepatitis, autoimmune conditions, medication effects, and inherited liver conditions depending on the pattern.
If direct bilirubin is elevated, the workup moves more toward hepatobiliary causes. A person may need imaging, especially if ALP and GGT are high or symptoms suggest gallstones or bile duct blockage. This is where comparing indirect bilirubin with direct versus indirect bilirubin patterns can be especially helpful.
Practical steps before a repeat test
For a non-urgent, mild indirect bilirubin elevation, clinicians may repeat the test under steadier conditions. Helpful steps include eating normally, avoiding prolonged fasting, staying well hydrated, avoiding unusually intense exercise for a day or two if advised, and making sure the clinician knows about all prescription medicines, over-the-counter medicines, supplements, recent illnesses, and alcohol intake.
Do not stop prescribed medicines just because bilirubin is high unless a clinician tells you to. Some medicine-related bilirubin changes are expected and harmless, while others can signal liver injury. The difference depends on the drug, bilirubin fraction, liver enzymes, symptoms, and timing.
When to Seek Medical Care
A mild isolated indirect bilirubin elevation can be low-risk, but bilirubin should not be ignored when symptoms are present or the result is new, rising, or unexplained.
Seek prompt medical care if jaundice appears with:
- Fever or chills
- Severe right upper abdominal pain
- Persistent vomiting
- Dark urine or pale stools
- Confusion, sleepiness, fainting, or personality changes
- Severe weakness or shortness of breath
- Chest pain or rapid heartbeat
- Black or bloody stools
- Easy bruising or bleeding
- Rapidly worsening yellowing of the eyes or skin
- New anemia or very low hemoglobin
- Recent transfusion followed by fever, back pain, dark urine, or jaundice
People with known liver disease, pregnancy, cancer treatment, HIV treatment, inherited blood disorders, sickle cell disease, G6PD deficiency, or recent medication changes should contact their clinician sooner when bilirubin rises.
For many adults, the most reassuring pattern is stable, mild, mostly indirect bilirubin with normal liver enzymes and no hemolysis. The most concerning patterns are bilirubin elevation with abnormal liver enzymes, high direct bilirubin, anemia, abnormal hemolysis markers, systemic symptoms, or signs of impaired bile flow.
Indirect bilirubin is a useful clue, not a complete diagnosis. It becomes much more meaningful when read as part of the whole pattern: total and direct bilirubin, liver enzymes, blood counts, hemolysis markers, urine findings, symptoms, medication history, and whether the change is new or long-standing.
References
- Unconjugated Hyperbilirubinemia 2023 (Review)
- Gilbert Syndrome 2024 (Review)
- Bilirubin Blood Test 2024 (Official Medical Test Page)
- Physiology, Bilirubin 2022 (Review)
- Anemia Hemolytic Anemia 2022 (Official Health Topic)
- ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries 2017 (Guideline)
Disclaimer
Indirect bilirubin results should be interpreted with your clinician, especially if jaundice, anemia, abnormal liver enzymes, dark urine, pale stools, pain, fever, or new symptoms are present. Reference ranges and follow-up decisions vary by lab, age, medical history, medications, and the full pattern of results. This information is educational and does not replace medical diagnosis, urgent care, or individualized treatment.
